{
  "id": "571f33f10fd6f91b68000004",
  "type": "yesno",
  "question": "Have 5q35 microdeletions been implicated in Sotos syndrome development?",
  "ideal_answer": "Loss-of-function mutations of NSD1 and 5q35 microdeletions encompassing NSD1 are a major cause of Sotos syndrome (Sos), which is characterized by overgrowth, macrocephaly, characteristic facies, and variable intellectual disability (ID).",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/25510705",
    "http://www.ncbi.nlm.nih.gov/pubmed/18505455",
    "http://www.ncbi.nlm.nih.gov/pubmed/12900893",
    "http://www.ncbi.nlm.nih.gov/pubmed/16140999",
    "http://www.ncbi.nlm.nih.gov/pubmed/23190751",
    "http://www.ncbi.nlm.nih.gov/pubmed/15805156",
    "http://www.ncbi.nlm.nih.gov/pubmed/24670087",
    "http://www.ncbi.nlm.nih.gov/pubmed/24192683",
    "http://www.ncbi.nlm.nih.gov/pubmed/22012791",
    "http://www.ncbi.nlm.nih.gov/pubmed/23913520"
  ],
  "snippets": [
    {
      "text": "Loss-of-function mutations of NSD1 and 5q35 microdeletions encompassing NSD1 are a major cause of Sotos syndrome (Sos), which is characterized by overgrowth, macrocephaly, characteristic facies, and variable intellectual disability (ID)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23913520",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We observed a novel 3.5 Mb 5q subtelomeric deletion in a 3-year-old girl with developmental delay, hypotonia and multiple minor anomalies. Comparison of her phenotype with the few published patients with terminal 5q35 deletions revealed several overlapping features, but also showed remarkable differences such as shortness of stature versus macrosomia. After the report of 5q35.3 microdeletions in Sotos syndrome we integrated the published BACs into the public draft sequence and exactly mapped the deletion size in our patient by FISH analysis with 15 BAC probes. We demonstrated that the deletion in our patient is immediately adjacent to the reported Sotos syndrome deletion site",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12900893",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Switch in FGFR3 and -4 expression profile during human renal development may account for transient hypercalcemia in patients with Sotos syndrome due to 5q35 microdeletions.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24670087",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Multiple mechanisms are implicated in the generation of 5q35 microdeletions in Sotos syndrome.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15805156",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "After the report of 5q35.3 microdeletions in Sotos syndrome we integrated the published BACs into the public draft sequence and exactly mapped the deletion size in our patient by FISH analysis with 15 BAC probes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12900893",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Clinical and genetic spectrum of 18 unrelated Korean patients with Sotos syndrome: frequent 5q35 microdeletion and identification of four novel NSD1 mutations.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23190751",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Here we describe a new case of Sotos syndrome with a 5q35 microdeletion, affecting the fibroblast growth factor receptor 4 (FGFR4) gene, presenting with infantile hypercalcemia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24670087",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Microdeletions at 5q35.3, encompassing NSD1, are responsible for approximately 10% of non-Japanese cases of Sotos.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15805156",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Alu-related 5q35 microdeletions in Sotos syndrome.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18505455",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Most cases of Sotos syndrome are caused by intragenic NSD1 mutations or 5q35 microdeletions.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16140999",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Multiple mechanisms are implicated in the generation of 5q35 microdeletions in Sotos syndrome",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15805156",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Clinical and genetic spectrum of 18 unrelated Korean patients with Sotos syndrome: frequent 5q35 microdeletion and identification of four novel NSD1 mutations",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23190751",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Microdeletions at 5q35.3, encompassing NSD1, are responsible for approximately 10% of non-Japanese cases of Sotos",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15805156",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A case of Sotos syndrome with 5q35 microdeletion and novel clinical findings.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24192683",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Here we describe a new case of Sotos syndrome with a 5q35 microdeletion, affecting the fibroblast growth factor receptor 4 (FGFR4) gene, presenting with infantile hypercalcemia. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24670087",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "There are two types of mutations that cause NSD1 haploinsufficiency: mutations within the NSD1 gene (mutation type) and a 5q35 submicroscopic deletion encompassing the entire NSD1 gene (deletion type). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22012791",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "aCGH and metaphase FISH are useful for rapid diagnosis of 5q35 microdeletion associated with Sotos syndrome.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25510705",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Multiple mechanisms are implicated in the generation of 5q35 microdeletions in Sotos syndrome.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15805156",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Switch in FGFR3 and -4 expression profile during human renal development may account for transient hypercalcemia in patients with Sotos syndrome due to 5q35 microdeletions.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24670087",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "A case of Sotos syndrome with 5q35 microdeletion and novel clinical findings.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24192683",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Most cases of Sotos syndrome are caused by intragenic NSD1 mutations or 5q35 microdeletions.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16140999",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "aCGH and metaphase FISH are useful for rapid diagnosis of 5q35 microdeletion associated with Sotos syndrome.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25510705",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Alu-related 5q35 microdeletions in Sotos syndrome.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18505455",
      "beginSection": "title",
      "endSection": "title"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}